IL17A and rheumatoid arthritis: Although RA patients have abnormally high levels of Treg cells in their synovial fluid (136–140), these cells frequently have defective suppressive activity, and certain Foxp3+Treg cells may transform into pathogenic Th17 cells that secrete IL-17, thereby exacerbates inflammatory responses (141).